ROXANNE S. AUSTIN - 06 May 2022 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
Steven L. Scrogham, attorney-in-fact for Roxanne S. Austin
Issuer symbol
ABBV
Transactions as of
06 May 2022
Net transactions value
$0
Form type
4
Filing time
09 May 2022, 17:10:27 UTC
Previous filing
12 Apr 2022
Next filing
10 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Award $0 +1,421 +2.9% $0.000000 50,705 06 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).